Website profile

Indian Pharma Post

Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com

  • 188articles · 30d
  • 9+ hour agolatest article
  • Aug 14, 2026earliest in window
  • 89%with images
  • 244avg words
articles per day
Categories
  • HTH 138
  • HW 102
  • economy business and finance 80
  • health 75
  • BI 65
  • FIB 33
  • science and technology 21
  • NW 14
Bylines

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@pharma_indian
indianpharmapost.com > rd > osivax-and-gc-biopharma-partner-on-next-generation-flu-vaccine-21642

Osivax and GC Biopharma partner on next-generation flu vaccine

1+ week, 5+ day ago   (55+ words) Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a decade IPC launches 12 reference standards to strengthen quality of phytopharma Cipla’s InvaGen plant in New York gets VAI status from…...

@pharma_indian
indianpharmapost.com > drug-approval > biocon-gets-us-fda-approval-for-yesintek-prefilled-autoinjectors-21415

Biocon gets US FDA approval for Yesintek prefilled autoinjectors

3+ week, 5+ day ago   (229+ words) Biocon Limited’s US subsidiary has received supplemental approval from the US Food and Drug Administration (FDA) for two new single-dose prefilled autoinjector presentations of Yesintek, expanding the company’s treatment options for patients with chronic autoimmune diseases. The FDA has approved…...

@pharma_indian
indianpharmapost.com > news > aptar-pharma-and-aceso-therapeutics-partner-to-advance-novel-cystic-fibrosis-drug-candidate-21774

Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate

4+ day, 3+ hour ago   (88+ words) Indian Pharma Post Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device assessment for ACT-101, supporting Aceso’s clinical development roadmap Chasing Consistency:…...

@pharma_indian
indianpharmapost.com > digitisation > sanofi-signs-three-year-partnership-with-tricog-to-scale-ai-powered-cardiac-diagnostics-21750

Sanofi signs three-year partnership with Tricog to scale AI-powered cardiac diagnostics

5+ day, 20+ hour ago   (374+ words) Under the proposed three-year collaboration, Sanofi will provide Tricog Health with mentorship, market access support and potential financial investment Prateek Golecha, Chief Growth Officer, Tricog Health (L) with Deepak Arora, Managing Director, Sanofi India (R) Sanofi Healthcare India Pvt. Ltd. has signed…...

@pharma_indian
indianpharmapost.com > news > ciplas-invagen-plant-in-new-york-gets-vai-status-from-usfda-21630

Cipla’s InvaGen plant in New York gets VAI status from USFDA

1+ week, 6+ day ago   (290+ words) FDA classifies July inspection of InvaGen Pharmaceuticals’ Unit 3 facility as Voluntary Action Indicated following review of manufacturing operations Cipla Limited has informed stock exchanges that the US Food and Drug Administration (USFDA) has classified its recent inspection of InvaGen Pharmaceuticals…...

Google News
indianpharmapost.com > news > fibrobiologics-bags-us-patent-for-fibroblast-based-wound-healing-21744

FibroBiologics bags US patent for Fibroblast-based wound healing

6+ day, 2+ hour ago   (57+ words) The technology targets some of the most difficult wounds to heal Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership to accelerate lab-to-market translation Fosun Pharma announces…...

@pharma_indian
indianpharmapost.com > healthcare > world-of-microbiome-2026-highlights-growing-role-of-microbiome-science-in-preventive-healthcare-21501

World of Microbiome 2026 highlights growing role of microbiome science in preventive healthcare

3+ week, 23+ hour ago   (315+ words) Leucine Rich Bio Pvt Ltd, the company behind BugSpeaks, hosted the third edition of World of Microbiome 2026 in Bengaluru, bringing together clinicians, researchers, nutritionists, biotech leaders, entrepreneurs, investors and wellness professionals to discuss the growing role of microbiome science in…...

Google News
indianpharmapost.com > drug-approval > pfizer-and-biontech-bag-fda-nod-for-xfg-targeted-covid-19-vaccine-21647

Pfizer and BioNTech bag FDA nod for XFG-targeted COVID-19 vaccine

1+ week, 6+ day ago   (75+ words) The vaccine is not appropriate for people who have experienced a severe allergic reaction after a previous dose of COMIRNATY Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a…...

@pharma_indian
indianpharmapost.com > healthcare > syneos-health-opens-hyderabad-gcc-to-accelerate-ai-led-healthcare-innovation-21618

Syneos Health opens Hyderabad GCC to accelerate AI-led healthcare innovation

2+ week, 1+ day ago   (312+ words) New hub, Syneos Health’s largest in Asia and third-largest globally, will focus on AI, data engineering and technology for clinical development, patient safety and commercialisation US-based biopharmaceutical solutions company Syneos Health has launched a new Global Capability Centre (GCC) in…...

@pharma_indian
indianpharmapost.com > drug-approval > lupin-gets-us-fda-nod-for-modafinil-tablets-21717

Lupin gets US FDA nod for Modafinil tablets

1+ week, 1+ day ago   (155+ words) Global pharmaceutical major Lupin Limited has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP, 100 mg and 200 mg. The approved tablets are bioequivalent to Provigil, the reference listed drug…...

Web

External web results are waiting for the human check. Complete the press-and-hold control above. Google advertising and AI choices remain separate after verification.